当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:6年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86095
参观次数:4057500
已选条件
-
T77073Losatuxizumab;化合物 LosatuxizumabLosatuxizumab
Losatuxizumab (ABT-806), an anti-EGFR monoclonal antibody, exhibits selective binding affinity towards various EGFR forms, with EC50 values of 0.96 nM for the wild-type EGFR, 0.09 nM for the C271A,C283A mutant, 0.12 nM for EGFRvIII, and 0.66 nM for EGFR1-501. It is utilized in research targeting EGFR-expressing cancers [1] [2].
价 格:¥电议型 号:T77073产 地:中国大陆
-
T77072Lorigerlimab;化合物 LorigerlimabLorigerlimab
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting (DART) antibody that blocks both PD-1 and CTLA-4, enhancing T-cell responses. It is under investigation for the treatment of metastatic castration-resistant prostate cancer (mCRPC) [1] [2] [3].
价 格:¥电议型 号:T77072产 地:中国大陆
-
T77071Lonigutamab;化合物 LonigutamabLonigutamab
Lonigutamab (hz208F2-4), a humanized monoclonal antibody targeting IGF-1R, facilitates the creation of antibody-drug conjugates (ADC) [1].
价 格:¥电议型 号:T77071产 地:中国大陆
-
T77070Loncastuximab;化合物 LoncastuximabLoncastuximab
Loncastuximab (RB4v1.2), an anti-CD19 monoclonal antibody, exhibits antitumor properties and holds potential for treating non-Hodgkin´s lymphoma (NHL), specifically diffuse large B-cell lymphoma (DLBCL) [1] [2].
价 格:¥电议型 号:T77070产 地:中国大陆
-
T77069Lomtegovimab;化合物 LomtegovimabLomtegovimab
Lomtegovimab (BI 767551), a humanized monoclonal antibody targeting the SARS-CoV-2 spike glycoprotein, exhibits antiviral efficacy by binding to and neutralizing the virus. This compound holds potential for COVID-19 research [1] [2].
价 格:¥电议型 号:T77069产 地:中国大陆
-
T77068Lodapolimab;化合物 LodapolimabLodapolimab
Lodapolimab (LY3300054) is an IgGλ anti- PD-1 monoclonal antibody [1] .
价 格:¥电议型 号:T77068产 地:中国大陆
-
T77067Livmoniplimab;化合物 LivmoniplimabLivmoniplimab
Livmoniplimab (ABBV-151; ARGX-115), a potent humanized monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, inhibits LRRC32-mediated activation of latent TGFβ1. This compound shows promise for cancer research [1].
价 格:¥电议型 号:T77067产 地:中国大陆
-
T77066Lilotomab;化合物 LilotomabLilotomab
Lilotomab (HH1), a murine anti-CD37 monoclonal antibody, demonstrates anti-tumor activity by reducing clonogenic survival [1].
价 格:¥电议型 号:T77066产 地:中国大陆
-
T77065Ligufalimab;化合物 LigufalimabLigufalimab
Ligufalimab (AK 117), a humanized IgG4 monoclonal antibody targeting CD47, does not lead to red blood cell (RBC) hemagglutination but promotes phagocytosis and exhibits anti-tumor activity [1].
价 格:¥电议型 号:T77065产 地:中国大陆
-
T77064Licaminlimab;化合物 LicaminlimabLicaminlimab
Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment that targets TNF alpha, an inflammatory cytokine produced by macrophages and monocytes during inflammation [1].
价 格:¥电议型 号:T77064产 地:中国大陆
-
T77063Libivirumab;化合物 LibivirumabLibivirumab
Libivirumab (17.1.41), a humanized monoclonal antibody targeting hepatitis B virus (HBV), demonstrates neutralizing activity with half maximal inhibitory concentrations (IC50) of 35 ng/mL for HBsAg and 130 ng/mL for HBeAg, respectively [1].
价 格:¥电议型 号:T77063产 地:中国大陆
-
T77062Levilimab;化合物 LevilimabLevilimab
Levilimab (BCD-089), a fully human monoclonal antibody targeting the interleukin-6 receptor (IL-6R), serves as an inflammation-reducing agent. This compound is utilized in the study of rheumatoid arthritis [1].
价 格:¥电议型 号:T77062产 地:中国大陆
-
T77061Letolizumab;化合物 LetolizumabLetolizumab
Letolizumab (BMS-986004), a monoclonal antibody directed at CD40L, is engineered to express a mutant IgG1 devoid of effector functions, such as Fc binding and complement fixation. It effectively reduces rejection and thromboembolism while extending survival time [1] [2] [3].
价 格:¥电议型 号:T77061产 地:中国大陆
-
T77060Lesofavumab;化合物 LesofavumabLesofavumab
Lesofavumab (MHAB5553A) is a human IgG1κ anti- influenza B virus antibody [1] .
价 格:¥电议型 号:T77060产 地:中国大陆
-
T77057Lerdelimumab;化合物 LerdelimumabLerdelimumab
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2].
价 格:¥电议型 号:T77057产 地:中国大陆
-
T77056Lenvervimab;化合物 LenvervimabLenvervimab
Lenvervimab (GC1102) is a recombinant human IgG1-type hepatitis B immunoglobulin designed for the research of hepatitis B virus infection [1] [2].
价 格:¥电议型 号:T77056产 地:中国大陆
-
T77051Larcaviximab;化合物 LarcaviximabLarcaviximab
Larcaviximab (c4G7-N) is a chimeric monoclonal antibody of the IgG1 kappa class, specifically targeting the Ebola virus glycoprotein [1].
价 格:¥电议型 号:T77051产 地:中国大陆
-
T77050Laprituximab;化合物 LaprituximabLaprituximab
Laprituximab (J2898A), a humanized IgG1 anti-EGFR antibody, is utilized in the synthesis of the antibody-drug conjugate (ADC) IMGN289 [1].
价 格:¥电议型 号:T77050产 地:中国大陆
-
T76966Ublituximab;化合物 UblituximabUblituximab
Ublituximab (LFB-R603; TG-1101; TGTX-1101), a next-generation, type 1 chimeric monoclonal antibody, specifically targets a unique epitope on the CD20 antigen, demonstrating anticancer effects [1].
价 格:¥电议型 号:T76966产 地:中国大陆
-
T76932Blontuvetmab;化合物 BlontuvetmabBlontuvetmab
Blontuvetmab (AT 004), a caninized CD20 monoclonal antibody, is utilized in the study of Canine B-cell lymphoma [1].
价 格:¥电议型 号:T76932产 地:中国大陆